Unlock instant, AI-driven research and patent intelligence for your innovation.

Peptide-mhc compacts

A technology of HLA-C and HLA-A, applied in the field of HC compounding, can solve the problems of low signal-to-noise ratio of multimer staining, laborious design and verification, and instability, and achieve the effect of obvious commercial potential.

Pending Publication Date: 2021-02-05
派克特制药公司
View PDF15 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

First, the production, purification and refolding of MHC molecules expressed in E. coli inclusion bodies is laborious and yields lower yields of properly folded peptide-MHC complexes
Second, in the case of personalized on-demand TCR gene therapy targeting patient-specific neoepitopes, the turnaround time (in weeks) of commercial peptide synthesis is not compatible with the optimal timescale
Third, many predicted ligands cannot be used to screen T cells by this route because biophysical properties of the peptides (e.g., hydrophobicity) hinder their synthesis or exchange
Fourth, exchange efficiency is generally poor (<50% exchange efficiency for most predicted HLA-binding peptides)
The resulting mixture of correctly folded exchanged MHC and misfolded unlinked MHC results in polymeric staining with a low signal-to-noise ratio, a problem that is exacerbated when T cells are screened with multiplexed pools of peptide-MHC reagents
Fifth, the design and validation of conditional ligands for each new MHC allele is a laborious and not robust task

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Peptide-mhc compacts
  • Peptide-mhc compacts
  • Peptide-mhc compacts

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0222] Example 1: Design and Cloning of the comPACT Minigene Cloned by Restriction Digestion

[0223] Structure of the compPACT minigene used for restriction digestion:

[0224] Basic exemplary components of a compPACT minigene are a signal sequence directing protein secretion, a universal target sequence such as a restriction site or a primer binding site, an antigenic peptide (or neoantigen, NeoE), a second universal target site, a constant β2M, the extracellular domain of the MHC allele and a purification cluster that enables enzymatic modification (eg, biotinylation) and compPACT purification via an affinity tag. Clusters may also contain protease cleavage sites and linker sequences between peptide components. Minigenes can also contain cysteine ​​mutations that act as disulfide bond traps. A map of the comPACT minigene is shown in figure 1 middle. Additional restriction sites upstream and downstream of the MHC heavy chain sequence can be used to insert other MHC allel...

Embodiment 2

[0231] Example 2: Design and cloning of the comPACT minigene via primer annealing

[0232] In a third variation of MHC template-carrier ligation, PCR and restriction digestion are bypassed by annealing two reverse-complementary neoantigen-encoding primers. These primers were designed with 5' and 3' ends starting and ending in complementary sequences that mimic the overhangs from the restriction digest ( Figure 5 ). The sense and antisense primers were incubated with T4 polynucleotide kinase and ATP to phosphorylate the 5' ends ( Figure 22A ). When these primers anneal to each other, they form a double-stranded oligonucleotide sequence with overhanging nucleotides as if digested with restriction enzymes. The phosphorylated neoantigen insert is ligated into a pre-cut MHC template in the vector. The compPACT minigene has the same structure as described in Example 1. The ligation products were then used for PCR amplification of linear compPACT amplicons using bookend univer...

Embodiment 3

[0235] Example 3: Design and cloning of compPACT minigenes assembled via PCR

[0236] Structure of the comPACT minigene used for PCR assembly:

[0237] A fourth method of inserting neoantigens can also be used. In this method, neoantigens are inserted via polymerase chain reaction into an MHC template flanked by an upstream promoter and a downstream polyadenylation signal to form a 2.5 kb minigene. The PCR assembly reaction is shown in Image 6 middle.

[0238] In this example, the comPACT minigene is shown with the following structure: a promoter at the 5' end; a signal sequence with a first universal target sequence; an antigenic peptide; a linker sequence with predominant glycine and serine residues (i.e., the GlySer linker ); the β2M sequence; the second Gly-Ser linker sequence; the MHC heavy chain allele; the third Gly-Ser linker sequence; the purification cluster; and the polyA sequence. In this method the universal target sequences are not identical.

[0239]PCR as...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed herein are antigenic peptide-MHC molecules, termed comPACTs, and methods of producing such molecules. Also disclosed herein are methods of producing libraries of comPACT polynucleotides andpolypeptides, and their exemplary use in capturing cancer neoepitope-reactive T cells.

Description

[0001] cross reference [0002] This application claims priority to U.S. Provisional Application No. 62 / 651,639, filed April 2, 2018, which is hereby incorporated by reference in its entirety for all purposes. [0003] sequence listing [0004] This application contains a Sequence Listing, which was submitted via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on XX, 20XX, is named XXXXXUS_sequencelisting.txt and is X,XXX,XXX bytes in size. Background technique [0005] T cells are the main mediators of adaptive immunity. Guided by the specificity of each T cell's unique T cell receptor (TCR), T cells regulate autoimmunity, help activate B cells and innate effectors, and directly kill infected and cancerous cells in a precisely targeted manner sex cells. Each TCR recognizes a ligand presented by a major histocompatibility complex (MHC) molecule on the target cell. Identification of relevant peptide-MHC complex ligands plays a role...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/74C07K14/705C07K14/435C07K16/30C07K16/28
CPCC07K14/70539C07K2319/00C07K2319/02C07K2319/20C07K2319/21C07K2319/50C07K14/61C12N15/1068G01N33/56972C12N15/62C40B40/06C12N5/0636C12N2510/00
Inventor 米凯尔·T·贝休恩凯尔·马丁·雅各比罗伯特·包晓研奥利维尔·达尔马斯潘政芭芭拉·森尼诺亚历克斯·弗兰祖索夫彭松明
Owner 派克特制药公司